
Indo Rama Synthetics (INDORAMA) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
12.0B
Gross Profit
2.6B
21.95%
Operating Income
650.8M
5.43%
Net Income
510.7M
4.26%
Balance Sheet Metrics
Total Assets
29.4B
Total Liabilities
25.7B
Shareholders Equity
3.7B
Debt to Equity
6.97
Cash Flow Metrics
Revenue & Profitability Trend
Indo Rama Synthetics Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 42.6B | 37.0B | 39.1B | 39.1B | 19.8B |
Cost of Goods Sold | 33.6B | 33.0B | 33.6B | 31.2B | 15.4B |
Gross Profit | 9.0B | 3.9B | 5.5B | 7.9B | 4.4B |
Gross Margin % | 21.2% | 10.7% | 14.1% | 20.1% | 22.4% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 984.4M | 1.2B | 1.8B | 746.3M |
Other Operating Expenses | 6.1B | 3.4B | 3.9B | 2.9B | 1.9B |
Total Operating Expenses | 6.1B | 4.3B | 5.1B | 4.7B | 2.7B |
Operating Income | 1.3B | -755.5M | 262.2M | 2.8B | 880.8M |
Operating Margin % | 3.1% | -2.0% | 0.7% | 7.1% | 4.4% |
Non-Operating Items | |||||
Interest Income | - | 26.3M | 124.5M | 49.4M | 39.9M |
Interest Expense | 1.6B | 1.2B | 496.3M | 489.4M | 600.4M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 14.0M | -2.0B | -247.2M | 2.2B | 33.9M |
Income Tax | 0 | 0 | 1.6M | -496.2M | -1.1B |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | -22.6% | -3,244.5% |
Net Income | 14.0M | -2.0B | -248.8M | 2.7B | 1.1B |
Net Margin % | 0.0% | -5.5% | -0.6% | 6.9% | 5.7% |
Key Metrics | |||||
EBITDA | 2.1B | -429.4M | 575.0M | 3.0B | 1.2B |
EPS (Basic) | - | ₹-7.79 | ₹-0.94 | ₹10.30 | ₹4.34 |
EPS (Diluted) | - | ₹-7.79 | ₹-0.94 | ₹10.30 | ₹4.34 |
Basic Shares Outstanding | - | 261113151 | 261113151 | 261113151 | 261113151 |
Diluted Shares Outstanding | - | 261113151 | 261113151 | 261113151 | 261113151 |
Income Statement Trend
Indo Rama Synthetics Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 242.1M | 236.6M | 560.4M | 35.1M | 24.4M |
Short-term Investments | 4.5B | 57.1M | 53.6M | 64.1M | 54.7M |
Accounts Receivable | 1.7B | 1.6B | 1.6B | 1.8B | 1.1B |
Inventory | 5.9B | 5.9B | 6.4B | 5.4B | 4.0B |
Other Current Assets | 999.9M | 100.0K | 1.3B | 880.0M | 581.1M |
Total Current Assets | 13.4B | 12.8B | 13.0B | 10.4B | 7.7B |
Non-Current Assets | |||||
Property, Plant & Equipment | 12.6B | 12.2B | 7.8B | 7.0B | 6.9B |
Goodwill | 500.0K | 1.1M | 3.2M | 5.6M | 800.0K |
Intangible Assets | - | 1.1M | 3.2M | 5.6M | 800.0K |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 275.9M | 340.0M | -14.9M | 624.2M | 252.8M |
Total Non-Current Assets | 16.0B | 16.3B | 14.2B | 10.7B | 9.5B |
Total Assets | 29.4B | 29.1B | 27.1B | 21.1B | 17.1B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 13.1B | 10.6B | 11.1B | 10.2B | 8.7B |
Short-term Debt | 7.7B | 9.5B | 3.1B | 1.5B | 1.5B |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 183.6M | 400.0K | 400.0K | 5.6M | 5.9M |
Total Current Liabilities | 21.5B | 21.1B | 15.2B | 12.7B | 11.0B |
Non-Current Liabilities | |||||
Long-term Debt | 3.7B | 3.9B | 5.8B | 2.0B | 2.5B |
Deferred Tax Liabilities | - | - | 0 | 1.6M | 600.0K |
Other Non-Current Liabilities | -100.0K | - | - | 10.3M | - |
Total Non-Current Liabilities | 4.1B | 4.3B | 6.2B | 2.4B | 2.8B |
Total Liabilities | 25.7B | 25.4B | 21.4B | 15.1B | 13.8B |
Equity | |||||
Common Stock | 2.6B | 2.6B | 2.6B | 2.6B | 2.6B |
Retained Earnings | - | -4.1B | -2.1B | -1.8B | -4.5B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 3.7B | 3.7B | 5.7B | 6.0B | 3.3B |
Key Metrics | |||||
Total Debt | 11.4B | 13.4B | 8.9B | 3.5B | 4.0B |
Working Capital | -8.2B | -8.3B | -2.2B | -2.3B | -3.4B |
Balance Sheet Composition
Indo Rama Synthetics Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 14.0M | -2.0B | -247.2M | 2.2B | 33.9M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -465.8M | -136.9M | -2.2B | -2.7B | -2.6B |
Operating Cash Flow | 886.8M | -888.8M | -2.1B | 34.3M | -2.1B |
Investing Activities | |||||
Capital Expenditures | -386.7M | -2.6B | -3.6B | -799.9M | -259.3M |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | - | - | -1.9M | - |
Investment Sales | - | - | 0 | 600.0K | 46.1M |
Investing Cash Flow | -370.4M | -2.6B | -3.6B | -803.1M | -167.1M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | -800.0K | -700.0K | -700.0K | -800.0K |
Debt Issuance | 4.8B | 1.1B | 4.6B | 387.4M | 0 |
Debt Repayment | -4.9B | -956.5M | -1.1B | -736.4M | -720.0M |
Financing Cash Flow | -1.9B | 4.5B | 5.4B | -561.6M | -937.7M |
Free Cash Flow | 3.5B | -3.6B | -4.5B | 1.2B | 1.6B |
Net Change in Cash | -1.4B | 1.0B | -286.8M | -1.3B | -3.2B |
Cash Flow Trend
Indo Rama Synthetics Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
1,028.80
Price to Book
3.65
Price to Sales
0.29
Profitability Ratios
Profit Margin
1.59%
Operating Margin
6.55%
Return on Equity
0.38%
Return on Assets
0.05%
Financial Health
Current Ratio
0.62
Debt to Equity
308.61
Beta
0.22
Per Share Data
EPS (TTM)
₹0.05
Book Value per Share
₹14.10
Revenue per Share
₹177.22
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
indorama | 13.5B | 1,028.80 | 3.65 | 0.38% | 1.59% | 308.61 |
KPR Mill | 324.7B | 39.37 | 6.49 | 16.30% | 12.60% | 9.32 |
Trident | 142.5B | 32.91 | 3.23 | 8.00% | 6.27% | 35.39 |
Indo Count | 48.6B | 23.59 | 2.14 | 10.80% | 4.94% | 63.61 |
Sanathan Textiles | 41.3B | 27.39 | 2.28 | 8.87% | 5.09% | 59.97 |
Raymond | 40.7B | 94.29 | 1.10 | 183.56% | 271.84% | 17.81 |
Financial data is updated regularly. All figures are in the company's reporting currency.